Condensed Statement of Cash Flows (Unaudited)	8 Months Ended
	Sep. 30, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (102,977)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in trust account	(41,254)
Unrealized loss on marketable securities	1,422
Deferred tax benefit	(299)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(134,716)
Accrued expenses	51,267
Net cash used in operating activities	(226,557)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(229,775,680)
Net cash used in investing activities	(229,775,680)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	225,180,170
Proceeds from sale of Private Units	5,945,510
Advance from related party	75,000
Repayment of advance from related party	(75,000)
Proceeds from promissory note—related party	133,000
Repayment of promissory note—related party	(133,000)
Payment of offering costs	(495,720)
Net cash provided by financing activities	230,629,960
Net Change in Cash	627,723
Cash — Beginning
Cash — Ending	627,723
Non-Cash investing and financing activities:
Initial classification of common stock subject to possible redemption	225,628,970
Change in value of common stock subject to possible redemption	(101,970)
Offering costs paid directly by Sponsor from proceeds from issuance of common stock	25,000
Issuance of Representative Shares	$ 820